GHDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Genomic Health Inc's account receivable for the three months ended in Mar. 2016 was $38.8 Mil. Genomic Health Inc's revenue for the three months ended in Mar. 2016 was $80.9 Mil. Hence, Genomic Health Inc's days sales outstanding for the three months ended in Mar. 2016 was 43.80.
During the past 13 years, Genomic Health Inc's highest Days Sales Outstanding was 47.19. The lowest was 23.30. And the median was 31.93.
Genomic Health Inc's days sales outstanding declined from Mar. 2015 (46.83) to Mar. 2016 (43.80).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Genomic Health Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as
Genomic Health Inc's Days Sales Outstanding for the quarter that ended in Mar. 2016 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Genomic Health Inc Annual Data
Genomic Health Inc Quarterly Data